Conference · Boston, Massachusetts
Immunogenicity of Protein Therapeutics
Health · Biology
Key numbers
- Editions on record
- 5first in 2011
About Immunogenicity of Protein Therapeutics
Assessment of immunogenicity for many types of biotherapeutics continues to challenge the industry. Investigators need to know how to develop and validate assays, when to perform them, and how to interpret the results as a meaningful risk assessment before moving into the clinic. The FDA requirement for neutralizing antibody assays is a particular hurdle. In the clinic, investigators need to work out how to deal with interfering drugs and to understand the significance of pre-existing antibodies. This conference will enable the investigator to work out an immunogenicity testing strategy for regulatory success and to ensure that their drug is both safe and efficacious.
From our listing of the 2014 edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 29–30 Apr 2015 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2014 | 7–8 May 2014 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2013 | 29–30 Apr 2013 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2012 | 3–4 May 2012 | The Boston Park Plaza Boston, Massachusetts | — | — |
| 2011 | 12–13 May 2011 | Sheraton Boston Hotel & Towers Boston, Massachusetts | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Immunogenicity of Protein Therapeutics?
The next dates haven't been confirmed. The last edition we have on record was 29–30 Apr 2015.
Where is it held?
The 2014 edition was at Seaport World Trade Center Boston, Boston, Massachusetts. The organiser hasn't confirmed the venue for this edition yet.
How often does it take place?
Annual, judging by the 5 editions on record since 2011.